How Do You Spell AGE RELATED MACULOPATHY?
Pronunciation: [ˈe͡ɪd͡ʒ ɹɪlˈe͡ɪtɪd mˌakjʊlˈɒpəθɪ] (IPA) 
Pronunciation: [ˈe͡ɪd͡ʒ ɹɪlˈe͡ɪtɪd mˌakjʊlˈɒpəθɪ] (IPA)
Age-related maculopathy, also referred to as age-related macular degeneration (AMD), is a degenerative eye condition that primarily affects older adults, specifically those above the age of 50. It is characterized by the deterioration of the macula, a region of the retina responsible for central vision and fine detail perception.
Age-related maculopathy is a progressive disease that can result in vision loss or legal blindness, particularly in individuals above the age of 75. There are two main types of age-related maculopathy: dry (non-exudative) AMD and wet (neovascular) AMD.
Dry AMD refers to the gradual breakdown of the macula due to the formation of yellowish deposits called drusen in the retinal pigment epithelium. This type often progresses slowly and may cause mild to moderate vision impairment.
Wet AMD, on the other hand, involves the development of abnormal blood vessels beneath the macula, which can leak fluid or blood, subsequently damaging the macula and causing rapid and severe vision loss. While less common than dry AMD, wet AMD often leads to more substantial visual impairment.
Risk factors for age-related maculopathy include advancing age, smoking, family history, and certain genetic factors. While the exact causes of age-related maculopathy are not fully understood, it is commonly believed to be a multi-factorial condition influenced by both genetic and environmental factors.
Regular eye examinations and early detection play a crucial role in the management of age-related maculopathy. Treatment options include lifestyle modifications, nutritional supplements, and in some cases, medical interventions such as injections or laser therapy.
